His primary areas of investigation include Internal medicine, Fatty liver, Endocrinology, Gastroenterology and Hepatitis C. His work in Cirrhosis, Nonalcoholic fatty liver disease, Insulin resistance, Steatosis and Liver biopsy is related to Internal medicine. His biological study spans a wide range of topics, including Diabetes mellitus, Physical therapy and Obesity, Weight loss.
Jacob George has included themes like Hepatitis B, Surgery and Hazard ratio in his Gastroenterology study. His study looks at the relationship between Hepatitis C and fields such as Hepatitis C virus, as well as how they intersect with chemical problems. The Immunology study combines topics in areas such as Fibrosis and Genotype.
Jacob George mainly focuses on Internal medicine, Gastroenterology, Fatty liver, Immunology and Endocrinology. His study in Internal medicine focuses on Cirrhosis, Fibrosis, Nonalcoholic fatty liver disease, Hepatitis C and Liver disease. His Fibrosis research integrates issues from Inflammation, Hepatic stellate cell and Receiver operating characteristic.
In the subject of general Gastroenterology, his work in Hepatology is often linked to In patient, thereby combining diverse domains of study. His research integrates issues of Steatosis and Obesity in his study of Fatty liver. His Immunology study frequently draws connections to other fields, such as Genotype.
Jacob George focuses on Internal medicine, Fatty liver, Disease, Gastroenterology and Cirrhosis. His research in the fields of Liver disease, Obesity and Nonalcoholic fatty liver disease overlaps with other disciplines such as Context. The study incorporates disciplines such as Portal hypertension, Hepatitis C, Hepatic encephalopathy and Hepatitis C virus in addition to Liver disease.
His Nonalcoholic fatty liver disease study integrates concerns from other disciplines, such as Endocrinology and Metabolic syndrome. His Fatty liver research is multidisciplinary, incorporating perspectives in Fibrosis, Steatosis, Liver cancer and CD163. His work investigates the relationship between Cirrhosis and topics such as Hepatocellular carcinoma that intersect with problems in Biomarker.
His primary areas of study are Disease, Fatty liver, Internal medicine, Coronavirus and Pandemic. His work on Nonalcoholic fatty liver disease is typically connected to Context as part of general Disease study, connecting several disciplines of science. The various areas that Jacob George examines in his Fatty liver study include Bioinformatics, Viral hepatitis, Cirrhosis, Hepatology and Fibrosis.
His work carried out in the field of Fibrosis brings together such families of science as Farnesoid X receptor, Steatohepatitis and Endocrinology. Jacob George has researched Internal medicine in several fields, including Gastroenterology and Diabetes mellitus. His work on Steatosis as part of his general Gastroenterology study is frequently connected to Moment, thereby bridging the divide between different branches of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie.
The New England Journal of Medicine (2011)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi;Quentin M. Anstee;Milena Marietti;Timothy Hardy;Timothy Hardy.
Nature Reviews Gastroenterology & Hepatology (2018)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi.
Hepatology (2007)
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
Vijayaprakash Suppiah;Max Moldovan;Golo Ahlenstiel;Thomas Berg.
Nature Genetics (2009)
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
Shivakumar Chitturi;Shehan Abeygunasekera;Geoffrey C. Farrell;Jane Holmes-Walker.
Hepatology (2002)
Beyond Insulin Resistance in NASH: TNF-alpha or Adiponectin?
Jason M. Hui;Alex Hodge;Geoffrey C. Farrell;James G. Kench.
Hepatology (2004)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee.
Journal of Hepatology (2020)
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Mohammed Eslam;Arun J Sanyal;Jacob George.
Gastroenterology (2020)
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Jason M Hui;Archana Sud;Geoffrey C Farrell;Priyanka Bandara.
Gastroenterology (2003)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi;Zobair Younossi;Frank Tacke;Marco Arrese;Barjesh Chander Sharma.
Hepatology (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of New South Wales
University of Turin
Australian National University
University of Western Australia
Royal Prince Alfred Hospital
University of Sydney
University of New South Wales
University of Seville
Macquarie University
University of New South Wales
Sapienza University of Rome
Santa Clara University
ETH Zurich
University of Tokyo
University at Buffalo, State University of New York
Hunan University
University of Lille
University of Münster
University of Utah
Universidade Federal de Minas Gerais
National Academies of Sciences, Engineering, and Medicine
Centers for Disease Control and Prevention
University of Guelph
University of Oregon
University of Milan
University of Paris-Saclay